TY - JOUR
T1 - American society for preventive cardiology 2024 cardiovascular disease prevention
T2 - Highlights and key sessions
AU - Chandra, Akhil A.
AU - Espiche, Carlos
AU - Maliha, Maisha
AU - Virani, Salim S.
AU - Blumenthal, Roger S.
AU - Rodriguez, Fatima
AU - Wong, Nathan D.
AU - Gulati, Martha
AU - Slipczuk, Leandro
AU - Shapiro, Michael D.
N1 - Publisher Copyright:
© 2024 The Author(s)
PY - 2025/3
Y1 - 2025/3
N2 - Groundbreaking strategies for preventive cardiology were showcased at the 2024 American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease (CVD) Prevention held in Salt Lake City, Utah, from August 2nd to 4th, 2024. The event featured 69 moderators and 13 scientific sessions comprised of 98 topics, 36 satellite events, 133 poster presentations, and 27 lifestyle classes. The conference highlighted innovative strategies focused on integrating cardiovascular, kidney, and metabolic health, presenting a cohesive approach for managing complex, interrelated conditions. Pivotal studies have addressed the role of lipid-lowering therapies, the benefits of early statin initiation, and the importance of precision medicine in preventing CVD. The ASPC's emphasis on translating this research into practical clinical tools has the potential to revolutionize preventive care strategies, making strides toward reducing the burden of CVD globally and improving long-term patient outcomes through personalized and early intervention approaches.
AB - Groundbreaking strategies for preventive cardiology were showcased at the 2024 American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease (CVD) Prevention held in Salt Lake City, Utah, from August 2nd to 4th, 2024. The event featured 69 moderators and 13 scientific sessions comprised of 98 topics, 36 satellite events, 133 poster presentations, and 27 lifestyle classes. The conference highlighted innovative strategies focused on integrating cardiovascular, kidney, and metabolic health, presenting a cohesive approach for managing complex, interrelated conditions. Pivotal studies have addressed the role of lipid-lowering therapies, the benefits of early statin initiation, and the importance of precision medicine in preventing CVD. The ASPC's emphasis on translating this research into practical clinical tools has the potential to revolutionize preventive care strategies, making strides toward reducing the burden of CVD globally and improving long-term patient outcomes through personalized and early intervention approaches.
KW - Lipids
KW - Precision medicine
KW - Preventative cardiology
UR - http://www.scopus.com/inward/record.url?scp=85212226886&partnerID=8YFLogxK
U2 - 10.1016/j.ajpc.2024.100919
DO - 10.1016/j.ajpc.2024.100919
M3 - Review article
AN - SCOPUS:85212226886
SN - 2666-6677
VL - 21
JO - American Journal of Preventive Cardiology
JF - American Journal of Preventive Cardiology
M1 - 100919
ER -
